Levels of CCL20, TNFα, MMP-9, IL-2, IGFBP-1, soluble Fractalkine, IL-10, soluble TWEAK were significantly higher in patients with AAA, whereas plasma levels of MMP-2 were significantly higher in AD patients. The gene discussed is CCL20; the disease is triple-A syndrome.